Etazolate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameEtazolate
Drug Alias Name依他唑酯etazolatoetazolatumEHT-202EHT-0202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulatorsAlpha secretases stimulantsPhosphodieterase 4 inhibitors
TargetsGamma-aminobutyric acid A receptorPhosphodieterase 4Alpha secretases
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb CompanyDiaxonhit
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExonhit
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG